When we examined the correlation between RGS6 expression and important clinical parameters, we found that metastatic lung cancer tissues possessed even lower levels of RGS6 compared to non-metastatic tumor tissues (Fig. 1D), whereas no significant correlation was found between RGS6 expression and other clinical parameters examined (Supplementary Table S2). Here, RGS6 is linked to neoplasm.